Loading
Latest filing published 06 Jul 2022 for Seres Therapeutics, Inc., €97k. Read the official filing
No signal scores available.
Only one filing by Meryl Zausner is known so far (6 July 2022): a share grant, €97k, in Seres Therapeutics, Inc. That is too little to draw conclusions. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration